Politico With the Weakest Scoop on Lindsey Graham's Replacement
With Extreme Poverty at All-Time Lows, Democratic Socialists Hope to Reverse the Trend
After Ousting Graham Platner in Maine, Bernie Sanders Says President Trump Doesn't Believe...
Representation Matters in Movies, Right Up Until It Doesn't
Did Jon Ossoff Really Say This About Liberty and Supporting ICE?
CNBC Lists the Ten 'Worst' States to Live In. See If You Can...
The New York Times Explainer for Its Catch-and-Kill Report to Benefit Graham Platner
To Democrats, the Economy Is Just One Massive Jobs Program
These Three Arizona Democrats Are Backed by the Soros Family
World Cup Star Erling Haaland Made Some Hilarious Texan Purchases Before His Return...
Iranian Drones in Cuba? Here's What Trump Knows.
Rents Hit All-Time High in Mamdani's NYC As Millionaires Make Mass Exodus
Iran Launches Strikes Against Maritime Vessels in the Strait of Hormuz
Twelve Democrat States Block Paramount Merge with Warner Bros
A Grand Prix Race Heads to DC – But It Wasn't An Easy...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos